1223 Cost-effectiveness of radium-223 compared to best standard of care, abiraterone acetate and enzalutamide in the treatment of castration resistant prostate cancer in the Netherlands. (September 2015) - De Meijer, C.; Baka, A.; Leliveld-Kors, A.; Noordzij, W.; Gaultney, J.